A new visit to the opening of the center: GALACTIC-1 phase IIb clinical trial involving patients with Idiopathic Pulmonary Fibrosis, sponsored by the pharmaceutical company Galecto Bayotek AB, Denmark

The Site's participation in three clinical trials of drugs for the treatment of ulcerative colitis was approved by the sponsor of the study - the pharmaceutical company Pfizer.

A new visit of the site's initiation: sublingual immunotherapy of tree pollen allergy, sponsored by the pharmaceutical company ALK-Abello, Denmark. We invite patients from 5 to 17 years old!

Our Study Site was invited to participate in clinical trials conducted by the pharmaceutical company Bayer: new treatment of neurogenic bladder

Our partners

Protagonist
Gilead
Mithra
PRA Health Sciences
Pfizer
Rusmo-AG
Sanofi
Abbvie
Icon
Astra Zeneca
Gedeon Richter
Cromos Pharma
PPD
X7 Research
Synteract
IQVIA
Biorasi | Built for Faster Clinical Trials
PSI
ALK
Galecto
SRG
Clinipas
Astellas
Janssen
JonsonAndJonson
OCT
Celgen
Bristol-Myers Squibb Company
Biogen